Zabala-Findlay, A.; Penny, L.K.; Lofthouse, R.A.; Porter, A.J.; Palliyil, S.; Harrington, C.R.; Wischik, C.M.; Arastoo, M.
Utility of Blood-Based Tau Biomarkers for Mild Cognitive Impairment and Alzheimer’s Disease: Systematic Review and Meta-Analysis. Cells 2023, 12, 1184.
https://doi.org/10.3390/cells12081184
AMA Style
Zabala-Findlay A, Penny LK, Lofthouse RA, Porter AJ, Palliyil S, Harrington CR, Wischik CM, Arastoo M.
Utility of Blood-Based Tau Biomarkers for Mild Cognitive Impairment and Alzheimer’s Disease: Systematic Review and Meta-Analysis. Cells. 2023; 12(8):1184.
https://doi.org/10.3390/cells12081184
Chicago/Turabian Style
Zabala-Findlay, Alex, Lewis K. Penny, Richard A. Lofthouse, Andrew J. Porter, Soumya Palliyil, Charles R. Harrington, Claude M. Wischik, and Mohammad Arastoo.
2023. "Utility of Blood-Based Tau Biomarkers for Mild Cognitive Impairment and Alzheimer’s Disease: Systematic Review and Meta-Analysis" Cells 12, no. 8: 1184.
https://doi.org/10.3390/cells12081184
APA Style
Zabala-Findlay, A., Penny, L. K., Lofthouse, R. A., Porter, A. J., Palliyil, S., Harrington, C. R., Wischik, C. M., & Arastoo, M.
(2023). Utility of Blood-Based Tau Biomarkers for Mild Cognitive Impairment and Alzheimer’s Disease: Systematic Review and Meta-Analysis. Cells, 12(8), 1184.
https://doi.org/10.3390/cells12081184
